Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02124772
Title	Study to Investigate Safety, Pharmacokinetic (PK), Pharmacodynamic (PD) and Clinical Activity of Trametinib in Subjects With Cancer or Plexiform Neurofibromas and Trametinib in Combination With Dabrafenib in Subjects With Cancers Harboring V600 Mutations
Recruitment	Completed
Gender	both
Phase	Phase I
Variant Requirements	Yes
Sponsors	GlaxoSmithKline
Indications	neuroblastoma plexiform neurofibroma brain glioma Advanced Solid Tumor
Therapies	Trametinib Dabrafenib + Trametinib
Age Groups:	child
Covered Countries	USA \| GBR \| FRA \| CAN \| AUS